Resources
11th Annual Healthcare Investor Conference 2019
The conference, now in its 11th year, features leading speakers from the healthcare and investment communities, who will provide insight into future trends in the healthcare industry.
The audience consists of senior management from private and public companies across Europe’s life-sciences sector, as well as a number of investors and analysts from the investment community.
Clinical Trials in Alzheimer's Disease Asia-China Conference
The goal of the CTAD Asia -China Conference is to bring together Asian leaders on the treatment and management of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues that are essential to the development of the next generation of Alzheimer’s disease treatments.
This CTAD Asia - China Conference will focus largely on how to develop successful AD clinical trials worldwide through workshops on important topics for conducting clinical trials: methodology, database management of clinical trials, biomarkers, patient recruitment, etc.
International Congress of Parkinson's Disease and Movement Disorders
The International Parkinson and Movement Disorder Society (MDS) gathers thousands of the field's clinicians, researchers, trainees and industry supporters with an interest in the current research and approaches for the diagnosis and treatment of movement disorders on an annual basis at its International Congress of Parkinson's Disease and Movement Disorders®. The purpose of the MDS International Congress is to share ideas, encourage interest among all those involved in the care and research of movement disorders, to participate in the activities of MDS, and to advance the related clinical and scientific discipline.
View
Alzheimer’s Association International Conference
The Alzheimer's Association International Conference is the largest and most influential international meeting dedicated to advancing dementia science. It convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment, and improvements in diagnosis for Alzheimer’s disease.
View
London Tech Week - A Practical Guide to AI in Clinical Trials
Bringing a drug to market is an arduous task, with the process taking from between 10 to 15 years while costing billions. Therefore, with claims that AI will be able to transform this process by improving the efficiency and optimization of clinical trials, it is no surprise that it has generated intrigue across life science industries. This course will, through the investigation of key use cases, provide understanding on these questions and help management level staff make informed decisions regarding its use in their business.
View
EPAD General Assembly Meeting
The EPAD project will host its annual General Assembly meeting in Geneva. The event will bring together EPAD delegates to discuss progress, latest developments and future plans. In attendance will be scientists, researchers, representatives from pharmaceutical companies, patient organisations, SMEs, EPAD study site members, other experts and research participants from across many different countries.
HD-RSC Annual Meeting
The Huntington’s Disease Regulatory Science Consortium was formed with the goal of improving the regulatory path for emerging therapies for Huntington’s disease. This global initiative will facilitate collaboration among biopharma/technology industry partners, academic institutions, government agencies, and patient-advocacy organizations.
View
SCA Global Conference
The 1st Spinocerebellar Ataxia (SCA) Global Conference proved an exciting time for the Ataxia community, with a goal to assemble a global consortium for clinical studies of the spinocerebellar ataxias, (SCAs).
IXICO sponsored the event and presented a poster: ''Development of a fully automated method for MRI volumetry in ataxia''
121-128 of 133 results